Dishman Pharma receives EIR from USFDA for Balva facility
Dishman Pharmaceuticals has got the Establishment Inspection Reports (EIR) from the USFDA for its Balva facility. The company has said in a BSE filing that...
Download Unicorn Signals App
Powered By EquityPandit
